Other
How AI can make health care better
- Global Healthcare Challenge: The medical sector faces a critical shortage of doctors relative to a growing patient population, leading to treatment delays that can result in permanent conditions; approximately 10% of NHS clinic appointments are for eye issues (nearly 10 million annually), with patients suffering blindness due to wait times.
- AI Diagnostic Capabilities: AI systems developed by Dr. Keane and partners can diagnose over 50 eye diseases with accuracy comparable to human specialists but process retinal scans in seconds rather than hours or days.
- Projected Vision Impairment Growth: The World Health Organization estimates that global distance vision impairment and blindness figures, currently at 596 million and 43 million respectively (2020 data), will increase by approximately 50% by 2050.
- Data Privacy Controversies: Google DeepMind faces legal action regarding the potentially inappropriate transfer of personally identifying medical records for 1.6 million NHS patients, highlighting tensions between data utility and patient privacy.
- Privacy-Preserving Technology: Collaboration with machine learning startup BitFount utilizes a "switchboard" model where data never leaves its host location, aiming to secure patient information while enabling cross-institutional analysis.
- Market Growth Forecasts: The global healthcare AI market is projected to grow eightfold by 2027 compared to 2020 valuations, potentially accelerated if clinicians develop AI models independently rather than relying on coders.
- Novel Diagnostic Biomarkers: A non-coder deep learning model developed by clinician Dr. Kira Oberne's team successfully identified gender from retinal scans, a task previously undetectable by humans, suggesting AI can reveal new disease patterns and biomarkers.
- Accountability and "Black Box" Risks: Skeptics emphasize the "black box" nature of AI models, raising concerns regarding interpretability, traceability of errors, and the assignment of accountability when diagnostic or treatment decisions go wrong.
- Virtual Trials for Medical Devices: Researchers at the University of Leeds utilize AI to create 3D digital replicas of patients, allowing for the simulation of procedures and drug scenarios to test efficacy before human trials.
- Efficiency of Virtual Trials: A 2021 study demonstrated that virtual trials yielded results consistent with three separate clinical trials but required only three months of execution time and under £20,000 in costs, compared to the 6–8 years and £20–30 million typically required for physical trials.
- AI Evolution Roadmap: Experts distinguish between AI 1.0 (automation of repetitive tasks) and AI 2.0 (integration of physiological and physical knowledge), predicting a future where healthcare is inextricably linked to advanced, knowledge-driven AI systems.